Video Shorts

2:51
Recapping the Most Important Data and Developments From SGO 2026!
4 months ago
by
Caroline Seymour(+2 more)

0:40
Evaluating the Landscape of Radioligand Therapies in Prostate Cancer
4 months ago
by
Jeff Michalski, MD, MBA, FASTRO

1:13
Significance of the KEYNOTE-B96 Results in Recurrent PROC
4 months ago
by
Bradley Monk, MD, FACOG, FACS

0:35
Final OS Data From the ROSELLA Trial in PROC
4 months ago
by
Alexander B. Olawaiye, MD

0:39
Gathering Expert Insights at SGO 2026!
4 months ago
by
Caroline Seymour(+1 more)

0:28
Data From the CARE Trial in Recurrent/Advanced Endometrial Cancer
4 months ago
by
Yang Sun, MD

0:26
Efficacy of Pamirtecan in HER2-Expressing Endometrial Cancer
4 months ago
by
Bhavana Pothuri, MD

0:27
Using Social Media to Build a Presence in Gynecologic Oncology
4 months ago
by
Megan Hutchcraft, MD

0:27
Testing the Bispecific Antibody REGN5668 in Gynecologic Cancers
4 months ago
by
Roisin E. O'Cearbhaill, MD

4:19
OncLive News Roundup for the Week of 4/5
4 months ago
by
Chris Ryan(+1 more)

0:38
Preparing for SGO 2026 in Puerto Rico!
4 months ago
by
Caroline Seymour(+1 more)

0:39
Initiating Productive Conversations About Weight Gain During Breast Cancer Treatment
4 months ago
by
Patricia Jakel, MSN

1:05
When Is IM Nailing vs Endoprosthetic Reconstruction the Right Choice in Metastatic Bone Disease?
4 months ago
by
R. Lor Randall, MD, FACS

0:30
Why Real-World Data Are Critical for Targeted Therapy Use in Cholangiocarcinoma
4 months ago
by
Lipika Goyal, MD

0:30
Unpacking Real-World Use of Relugolix in Prostate Cancer
4 months ago
by
Rana R. McKay, MD

0:34
Breaking Down the Basics of Orca-T and its Development
4 months ago
by
Sagar Patel, MD

1:00
Molecular Profiling Is Reshaping Treatment in Cholangiocarcinoma
4 months ago
by
Lipika Goyal, MD

0:55
Unpacking the Significance of the FDA Approval of Brexu-Cel for MCL
4 months ago
by
Lore Gruenbaum, PhD

0:57
Delineating Adjuvant Radiation Therapy Modalities for Breast Cancer
4 months ago
by
Meghan R. Flanagan, MD, MPH

1:11
The Evolution of Follicular Lymphoma Management
4 months ago
by
Amitkumar Mehta, MD

3:42
OncLive News Roundup for the Week of 3/29
4 months ago
by
Chris Ryan(+1 more)

0:29
Investigating ADT Plus Pembrolizumab in Salivary Gland Carcinoma
4 months ago
by
Manish R. Patel, DO

1:59
Unpacking the Meaning of Microplastics in Prostate Cancer Samples
4 months ago
by
Stacy Loeb, MD

0:51
Examining Real-World Outcomes With Lutetium Lu 177 Vipivotide Tetraxetan
4 months ago
by
Mohammad Arfat Ganiyani, MBBS

0:45
Will Neoadjuvant Therapy Reshape the Future of CRC Management?
4 months ago
by
Marc Lehrer Greenwald, MD

0:37
The Potential Role of the SERENA-6 Data in Breast Oncology
4 months ago
by
Kevin Kalinsky, MD, MS

0:48
HPV Prevention and Screening Gaps Continue to Drive Anal Cancer Risk
4 months ago
by
Richard Kim, MD

2:46
Luspatercept and Frontline Treatment Decisions in Lower-Risk MDS
4 months ago
by
Jan Bewersdorf, MD, FACP

3:08
OncLive News Roundup for the Week of 3/22
4 months ago
by
Chris Ryan(+1 more)

1:05
BOOM Provides Consensus on Periprosthetic Joint Infection Management in Orthopedic Oncology—but Evidence Gaps Remain
4 months ago
by
R. Lor Randall, MD, FACS
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Rituximab Biosimilar for Hematologic Malignancies
2
Triplet Immunotherapy Regimen Yields Durable Responses in pMMR CRPC
3
Talk of Cure, a New ADC, and a Negative Trial: Breaking Down the Biggest Gynecologic Cancer News From ASCO 2026
4
Emerging Maintenance Strategies May be the Key to Extending Survival in ES-SCLC
5
